Countdown to 2022 CBIIC：

Expert Review Committee

JIANG Hualiang

Academician of Chinese Academy of Sciences
2015-2016 Annual Chairman of PhIRDA
Professor of Shanghai Institute of Materia Medica, Chinese Academy of Sciences

JIANG Jiandong

Academician of Chinese Academy of Engineering
2017-2018 Annual Chairman of PhIRDA
President of Institute of Pharmaceutical Sciences Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College

GU Ning

Academician of Chinese Academy of Sciences
Vice-Chairman of PhIRDA Digitalization in Pharmaceutical and Innovative Therapy Specialty Committee (preparatory)
Chief Professor of Southeast University

LI Jia

Director of Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Director of State Key Laboratory of Drug Research

HU Zhibin

Chairman of PhIRDA Digitalization in Pharmaceutical and Innovative Therapy Specialty Committee (preparatory)
Deputy Secretary of CPC & President of Nanjing Medical University

SHI Yuankai

Vice-Chairman of 2rd PhIRDA Clinical Trial Research Specialty Committee
Professor in Tenure, Chinese Academy of Medical Sciences & Peking Union Medical College
Chairman, Cancer Foundation of China

HUO Yong

Chairman of PhIRDA Clinical Research on Cardiovascular Drugs Specialty Committee
Chief Expert of Cardiology Department, Peking University First Hospital

JI Linong

Chairman of PhIRDA Clinical Research on Diabetes and Metabolic Diseases Specialty Committee
Director of Endocrinology and Metabolism Department, Peking University People's Hospital

LI Jin

Chairman of PhIRDA Clinical Research on Oncology Drugs Specialty Committee
Director of Department of Oncology, Shanghai East Hospital, Tongji University

LI Ning

Member of PhIRDA Clinical Research on Oncology Drugs Specialty Committee
President of Hebei Cancer Hospital, Chinese Academy of Medical Sciences

HU Xin

Chairman of PhIRDA Medicinal Policy Specialty Committee
Chief Pharmacist, Department of Pharmacy, Beijing Hospital

CUI Yimin

Chairman of PhIRDA Clinical Trial Research Specialty Committee
Director of Institute of Clinical Pharmacology, Peking University, PUICP

GAO Zhaobing

Deputy Director,Principal Investigator of Shanghai Institute of Materia Medica, Chinese Academy of Sciences

CHEN Xiaoguang

Member of PhIRDA Drug R&D Specialty Committee
Professor of Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College

WANG Xinghe

Vice-Chairman of PhIRDA Clinical Trial Research Specialty Committee
Chief Physician/Professor, Director of General Office of National Drug & Medical Device Clinical Trial Institute, Director of Phase I Clinical Trial Center

LI Haiyan

Vice-Chairman of PhIRDA Clinical Trial Research Specialty Committee
Director of Drug Clinical Trial Center, Peking University Third Hospital

LI Wenbin

Vice-Chairman & Secretary-General of Clinical Research on Cranial Nerve Drugs Specialty Committee
Chair of Cancer Center, Beijing Tiantan Hospital, Capital Medical University

ZHOU Bing

Professor, Principal Investigator of Shanghai Institute of Materia Medica, Chinese Academy of Sciences

HE Ruyi

Chairman of PhIRDA International Regulatory Science Specialty Committee
CMO of RemeGen, CMO of SDIC
Former Chief Scientist of CDE, CFDA

YANG Dajun

Chairman of PhIRDA Drug R&D Specialty Committee
Chairman of the Board & CEO of Ascentage Pharma

WANG Yinxiang

Vice-Chairman of PhIRDA Drug R&D Specialty Committee
Chairman of the Board & CEO of Jacobio Pharma

FANG Jianmin

Vice-Chairman of PhIRDA Drug R&D Specialty Committee
Co-Founder, CEO & CSO of RemeGen

LIANG Yingyu

Chairman-elected of Pharmaceutical Innovation Investment Specialty Committee
Managing Partner of Qiming Ventures

SUN Zhe

Director of Office for Digitalization on Pharmaceutical Innovation of PhIRDA
Secretary-General of PhIRDA Digitalization in Pharmaceutical and Innovative Therapy Specialty Committee (preparatory)
Managing Partner of Momentum Ventures
Register
  • 010-58156160
    Contact US